Outsourcing in Clinical Trials Southern California 2019
24th- 25th September 2019, La Jolla, California
The leading Outsourcing conference series returns to San Diego for its 7th year in September 2019. With a focus on providing delegates with practical take-aways and solutions to their most current operational and outsourcing challenges in clinical trials, this is an event not to be missed.
Not only will the audience be discussing ever-pressing partnership and outsourcing challenges, but we also have a dedicated track to clinical trial technology and data so you can stay up-to-date with new innovations that will help you accelerate your trial timelines.
In order to enhance collaboration and beneficial networking, the 2019 agenda also has a host of new interactive formats such as workshops, working lunch roundtables and breakout discussions.
There has already been high interest in this year’s conference and places are limited so be sure to register your attendance today!
WHAT TO EXPECT FOR 2019
The meeting place for healthcare pioneers and innovators
Join pharmaceutical, medical device and biotech experts to discuss new trends and opportunities and learn how to optimize their clinical operation knowledge and stay ahead of the game.
Find the right solution providers to partner with to accelerate your trial timelines.
ATTENDEES AT DIRECTOR + LEVEL
This is an exceptional networking opportunity for the biopharma and medical device industries. Meet industry C-Suite and Director level executives to make valuable connections at this annual clinical trial conference
Join like-minded peers working in clinical trials to learn new perspectives and case insight through presentations, panel discussions, interactive round-tables and workshops
The conference discusses the vital connections between process, tools and techniques to manage progress in clinical trials. Update your knowledge to create new strategies enabling you to enact change
With over 40 years’ experience, 600 beds and locations in NA, EU and Asia, Celerion conducts First-in-Human, clinical Proof-of-Concept and patient dose response studies, cardiovascular safety and NDA-enabling clinical pharmacology research. Celerion provides full study services including statistics, data management and biostatistics (including PK/PD analysis), and bioanalytical services.
KPS is a global, innovative, Clinical Outsourcing Provider delivering clinical trial monitoring, management and quality oversight services to pharmaceutical, biotechnology, medical device, and related industries. Founded and operated as a more customer centric and nimblealternative to traditional CROs, KPS offers a full range of services leveraging the latest clinical technologies.
Advanced Clinical is a global clinical research services organization, providing CRO, FSP, Strategic Resourcing and Consulting Services for biopharmaceutical and medical device organizations. Our company is committed to improving all lives touched by clinical research and we address the hopes of patients and healthcare professionals with industry-leading services and technology in life sciences. Visit our website to learn more about how we deliver a Better Clinical Experience.
At Axio Research, we focus on delivering timely, high-quality data and thoughtful analysis to help our clients address their scientific questions confidently and efficiently in four main areas of the clinical trials process:
• Data Monitoring Committee Support
• Biostatistics Design, Analysis, and Reporting
• Data Management Solutions
• Statistical Genetics and Genomics Services
As leaders in clinical trials services, experts from Cardiocore and VirtualScopics are the Research division of BioTelemetry, Inc., one of the world’s largest connected health companies.
As BioTel Research, they offer global operational support for cardiovascular monitoring in all therapeutic areas, and advanced imaging services in oncology, cardiovascular, metabolic, musculoskeletal, neurologic and medical device studies.
BioTel Research’s team is comprised of key opinion leaders, radiologists and board-certified cardiologists, sub-specialty scientists, and highly trained technicians — who acquire, evaluate, and report high-quality data through an efficient database infrastructure. For more information please visit www.gobio.com/clinical-research/
CROMSOURCE is an international contract research organization providing a comprehensive services to the pharmaceutical and biotechnology companies. Specializing in clinical development and staffing solutions, we offer a flexible approach to ensure our clients’ unique needs are supported. CROMSOURCE is unparalleled in offering an end-to-end guarantee covering trial timelines, enrollment, and price. CROMSOURCE operates offices across Europe and North America.
Nucleus Network is Australia’s premier dedicated Phase I clinical trials organization. Nucleus Network has an 80-bed clinical unit that is co-located with a major tertiary teaching hospital in Melbourne. We primarily work with FIH, Healthy Volunteers and have done patient studies with added cohorts.
Pharm-Olam International delivers cost effective, quality clinical services to pharma and biotech sponsors across all therapeutic areas in more than 40 countries. Since 1994, we have been committed to our objective: to create value for our clients by satisfying their clinical development needs with consistent and dependable solutions and services.
- Experience in a broad range of therapeutic areas
- Phase I-IV clinical trials
- Highly-skilled project management services
Stiris Research is an elite CRO focused on meeting client needs by providing highly experienced Project Management and Monitoring professionals for Phase I-IV clinical trials. Our strength is seamlessly integrating as an extension of your organization to assemble the perfect team and deliver a highly efficient, cost effective outsourcing solution.
Syneos Health (Nasdaq:SYNH*) is the only fully integrated biopharmaceutical solutions organization. Our company, including a Contract Research Organization (CRO) and Contract Commercial Organization (CCO), is purpose-built to accelerate customer performance to address modern market realities. Created through the merger of two industry leading companies – INC Research and inVentiv Health – we bring together more than 21,000 clinical and commercial minds with the ability to support customers in more than 110 countries. Together, we share insights, use the latest technologies and apply advanced business practices to speed our customers’ delivery of important therapies to patients. To learn more about how we are shortening the distance from lab to lifeTM visit SyneosHealth.com.
Translational Drug Development (TD2) is a world-class oncology drug development organization specializing in the development of new oncology medicines. TD2 offers fully integrated precision oncology clinical development solutions that combine the highest standards in clinical trials management, disruptive imaging, biomarker strategies, and unparalleled access to real-time patient data.
Schulman IRB and Chesapeake IRB have merged to create Advarra, the premier provider of IRB, IBC and global research compliance services. By integrating our innovative technology and proven regulatory expertise, Advarra helps ensure the highest standards of human research protections. Advarra supports all research phases across all major therapeutic areas.
Arena’s business-to-business events offer a myriad of opportunities for sponsors and exhibitors to drive their business forward. Our sponsorship packages help companies reach their target market and spread brand awareness throughout the industry.
If you want to discuss how we can help you generate leads and add-value to your corporate and brand image please contact:
T: +61 280 978 126
We identify and invite individuals we believe to be the best speakers in the market. If you think you can make a difference to the quality of our events please contact the programme director of the event:
T: + 44 (0) 207 936 6822